Japan Lifeline : Issues an Updated Version of Sponsored Research Report(116KB)
June 05, 2024 at 02:19 am EDT
Share
June 5, 2024
To whom it may concern,
Company: Japan Lifeline Co., Ltd.
Representative: Keisuke Suzuki, President and CEO (Code: 7575 TSE Prime Market)
Contact person: Takeyoshi Egawa, Vice President, Business Administration Department (TEL. +81-3-6711-5200)
Japan Lifeline Issues an Updated Version of Sponsored Research Report
Japan Lifeline Co, Ltd. ("the Company") is pleased to announce that Nippon Investment Bespoke Research UK Ltd (www.nippon-ibr.com) ("Nippon IBR"), an independent research firm, has issued a sponsored report on the Company today.
The Company requested Nippon IBR to write a sponsored report as part of its investor relations related activities to promote communications with investors. This report contains a concise summary of the Company's recent business performance and business strategies to help investors conduct their initial research. The report is mainly written in English, and the Japanese version is a translation.
You can read the latest reports including back numbers from below.
English report
Japanese report (translation)
Attachments
Original Link
Original Document
Permalink
Disclaimer
JLL - Japan Lifeline Co. Ltd. published this content on
05 June 2024 and is solely responsible for the information contained therein. Distributed by
Public, unedited and unaltered, on
05 June 2024 06:18:07 UTC.
Japan Lifeline Co., Ltd. is a Japan-based company mainly engaged in the import, manufacture and sale of cardiac circulators and other medical devices. The Company is mainly engaged in the production of rhythm devices, electrophysiological (EP) and ablations, surgical products and intervention products. The rhythm devices include cardiac pacemakers, implantable cardioverter defibrillator (ICD), cardiac resynchronization therapy defibrillator (CRT-D) and other rhythm devices. The EP and ablations include EP catheters for cardiac arrhythmia examination, ablation catheters for arrhythmia treatment and other EP and ablations. The surgical products include prosthetic heart valves and annuloplasty rings for heart disease surgical treatment, vascular grafts, open stent grafts and stent grafts for aortic disease treatment, as well as other surgical products. The intervention products include balloon catheters, guide wires, penetration catheters and other intervention products.
JAPAN LIFELINE CO., LTD. 
